Testing Suizenji for newly diagnosed pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests a new ultrasound treatment called Suizenji for people with pancreatic cancer that cannot be removed by surgery. The goal is to see if it can safely target the tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of pancreatic cancer that has spread or cannot be removed.
- You have not had any chemotherapy or other cancer treatment for this cancer yet.
- Your tumor can be seen on an ultrasound and can be reached by the ultrasound waves.
- You are age 18 or older and in generally good health (able to care for yourself).
- Your liver and kidney function are adequate based on routine blood tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether adding focused ultrasound (a treatment that uses sound waves to target the tumor) to standard chemotherapy can help shrink or control pancreatic cancer in people whose cancer is borderline resectable or locally advanced. It aims to see if this combination is more effective than chemotherapy alone.
This study is collecting information from people who may have pancreatic cancer to see how a new ultrasound imaging technique (called LINFU) works for helping doctors decide whether a biopsy is needed. Participation could provide better imaging to guide your care.
This trial tests a new drug called mitazalimab injected directly into the tumor, combined with a special electrical procedure that kills cancer cells. It is for people whose pancreatic cancer has not spread but cannot be removed by surgery.
This trial tests a precise type of radiation therapy guided by MRI for people with locally advanced pancreatic cancer. It aims to treat the tumor while protecting nearby healthy tissue, potentially improving outcomes after chemotherapy.
This trial tests a new kind of immunotherapy for pancreatic cancer that has not been removed by surgery or has spread. It aims to see if the treatment can help shrink or control the cancer, and you may be eligible whether you have had previous chemotherapy or not.
This study uses small pancreatic cancer samples grown in the lab to understand which treatments may work best for people with pancreatic cancer. It may help researchers better “profile” tumors so standard care can be matched to the most effective options.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.